Slim, superfit man diagnosed with deadly 'fat person' condition - common late night habit was to blame
Dance teacher Will McKechnie thought his trim figure and the fact he exercised seven times a week meant he was perfectly fit and healthy.
But the 66-year-old was shocked when medics warned him that his blood sugar were so high he was prediabetic.
The condition—suffered by millions unknowingly—is a precursor for potentially deadly type 2 diabetes and frequently linked to being overweight and obese.
Mr McKechnie, from Lytham St Annes, Lancashire, said he was floored by the diagnosis as he has prided himself on being active and was a svelte 11st 13lb.
'I was petrified at the idea that I might be starting to get poor health,' he said.
'Before I heard that I just thought everyone sometimes has a bit of high blood sugar.
'And before that, before the blood test, I honestly thought I was really fit and healthy.'
Mr McKechnie's condition was revealed during an NHS 'over 60s MOT' which discovered his average blood sugar levels were 44 mmol/mo—considered prediabetic, and just below the threshold for full blown diabetes.
Mr McKechnie, from Lytham St Annes, Lancashire, said he was floored by news he had prediabetes as he prided himself on being physically active
He now says he's changed both what and how he eats to bring his blood sugar levels under control and with great success
Any reading between 42 and 47 mmol/mo is considered prediabetic and above 48 mmol/mol is the diagnostic criteria for type 2 diabetes.
'When he (the GP) said it wouldn't be reversible over 48 (mmol/mo) I was terrified,' Mr McKechnie recalled.
The grandfather-of-four said he had wrongly assumed his active lifestyle meant he could eat whatever he wanted and admitted to tucking in to a Yorkie chocolate bar and packet of crisps each night.
He now says he's changed both what and how he eats to bring his blood sugar levels under control and with great success.
As well as cutting down on unhealthy snacks he also made effort to chew his meals slowly, which he says helps him feel fuller without eating as much.
He says it now takes him 40 minutes to eat his typical lunch of chicken sandwiches on wholemeal bread.
'I loved eating Yorkie bars and crisps, and ice cream. I just have a very occasional treat now, and much smaller,' he said.
In the nine months since making the changes his average blood sugar levels have dropped down to 41 mmol/mo meaning he is no longer considered prediabetic.
He also lost just under two stone, and trimmed two inches off his waist.
'I'm so relieved I had that test. It has changed my life and made me so much fitter,' he added.
Mr McKechnie said he originally had the blood test back in May 2023, but his GP only warned him of his prediabetes status a year later when looking over the results.
As such he's encouraging other Britons to consider getting a test.
'Even if you have to pay for it it's worth getting your blood sugar checked routinely. It's much much better to find out,' he said.
Mr McKechnie was lucky to be told he had prediabetes as the condition normally causes no symptoms, according to charity Diabetes UK.
If symptoms are present, they can include going to the toilet more often, fatigue, losing weight without trying, genital itching, minor cuts taking longer to heal, blurred vision and extreme thirst.
An estimated 6.3million Britons— about one eight of the population of England—are thought to have prediabetes with the vast majority unaware they have the condition.
While those most likely to develop the condition have known diabetes risk factors such as being overweight or older, younger and slimmer people can also have the condition.
Diabetes UK estimates that about half of cases of prediabetes can be prevented from developing into type 2 diabetes if patients make adjustments to their diet and lifestyle.
Diabetes is a potentially deadly illness which costs the NHS £10 billion a year to treat.
Type 2 diabetes occurs when the body doesn't make enough insulin or the insulin it makes doesn't work properly.
This hormone is needed to bring down blood sugar levels.
Having high blood sugar levels over time can cause heart attacks and strokes, as well as problems with the eyes, kidneys and feet.
Sufferers may need to overhaul their diet, take daily medication and have regular check-ups.
However, the term prediabetes isn't without controversy.
In fact, the inventor of the term Dr Richard Kahn, former chief scientific adviser to the American Diabetes Association recently claimed that doing so was 'a big mistake'.
Patients diagnosed as prediabetic have also given a mixed assessment of the term.
Earlier this year the Mail On Sunday reported how some patients said a diagnosis had 'saved' them while others said it had left 'frightened to death' about what they could eat.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
Why earwax can predict if you're at risk of developing Parkinson's disease
Published: | Updated: Scientists have revealed that the wax in your ears could actually say a lot about your health. Researchers in China have identified key differences in the makeup of earwax in people with Parkinson's disease compared to people without the condition, suggesting the sticky stuff holds secrets that could flag a person's risk of eventually developing the condition. Scientists at Zhejiang University took earwax samples from 100 people with Parkinson's and 79 without. They chose earwax because much of it is made up of sebum, an oily substance that undergoes chemical changes in cases of Parkinson's, and releases distinct volatile organic compounds (VOCs). Parkinson's triggers neurodegeneration, inflammation, and oxidative stress, altering sebum's composition and creating a distinct odor. It also progressively damages the brain, causing tremors, stiffness, and slow movement. Over time, symptoms worsen to include sudden freezing, speech loss, swallowing problems -often leading to pneumonia - and falls, both common causes of death among people with Parkinson's. Four specific types of VOCs stood out among people with the condition, suggesting that earwax could potentially be an accessible indicator of Parkinson's, which would allow patients to avoid invasive diagnostic tests and spinal taps. Around 1million Americans and 10million people globally currently have the disease, with nearly 90,000 new cases diagnosed each year. As that number is projected to climb, early diagnosis is more important than ever. While there is no cure, medication regimens can be started early to treat symptoms and slow down the progression of the disease. Researchers fed the VOC data from the samples of earwax into an algorithm that categorized subjects' Parkinson's status accurately 94 per cent of the time, demonstrating the potential for a fast, reliable diagnostic tool. The VOCs that stood out to researchers were all significant in differentiating between people with the condition and those without it, even after accounting for age and lifestyle factors. Two of the VOCS, Ethylbenzene & 4-Ethyltoluene, are compounds commonly found in plastics and petroleum products. Their presence suggests inflammation in the brain, which is a key driver of the breakdown of dopamine in the brain. Dopamine, while often thought of as a 'feel good' neurotransmitter, is a key chemical messenger that regulates movement control. As dopamine levels plummet while Parkinson's progresses, people become steadily more immobile. Another significant VOC was Pentanal, which is produced when fats break down. Elevated levels suggest cell damage, a hallmark of Parkinson's. The compound has been linked to an accumulation of protein clumps in patients' brains. And the VOC 2-Pentadecyl-1,3-dioxolane likely reflects issues with the metabolism of fats, which could have originated from microbiome changes in the skin of patients. It's unclear whether this VOC has any direct links to PD, but there is an expanding body of research pointing to a connection between PD and an imbalance in the gut microbiome. Soaring: Parkinson's death rates rose from 42 to 65 deaths per 100,000 from 1999–2017 Research suggests that VOCs are produced by the balance of good bacteria in the gut, which have also been associated with brain health. An imbalance allows harmful bacteria to flourish, leading to a proliferation of toxins that can cause inflammation in the brain. VOCs come from a wide array of toxic sources in the environment, from pesticides used to grow food, industrial chemicals in gasoline, and solvents in everyday items like dry cleaning chemicals and adhesives, to cleaning products, car emissions, and contaminated groundwater. Parkinson's is believed to be caused by a confluence of genetic and environmental factors. It is the world's fastest-growing brain disorder, and, according to NIH research, 'exposure to environmental toxicants is the principal reason.' In the US, deaths from Parkinson's disease have more than doubled in the past 20 years, with about 35,000 deaths in 2019 compared to 14,500 in 1999. While considering the clues that earwax can provide about Parkinson's development is new, investigating the role that VOCs play is not. A sweeping 2023 meta-analysis identified distinct VOCs present in the breath and skin oil in people with the disease compared to those without it. These compounds are specifically linked with oxidative stress, or a barrage of damage that cells endure before dying.
The Guardian
an hour ago
- The Guardian
I was diagnosed with PCOS – and was soon drowning in misinformation
I suspected I had polycystic ovary syndrome (PCOS) long before it was confirmed. The signs were there: the acne scars that littered my back, the irregular periods, the hair in places on my body that I didn't see on many of my friends. I suspected it from the moment that one of my best friends, who as a girl taught me about bleaching my body hair and waxing my legs, was diagnosed with it as a teenager. Admitting all this publicly feels like an unburdening, but also an invitation to more shame. But I write this because my experience is far from unique. As many as one in 10 women have PCOS, a condition associated with hormonal disturbances that can range from weight gain, 'unwanted' body hair and hair loss, to irregular periods and struggles to conceive children (including an increased risk of miscarriage). It can leave women more likely to develop high blood pressure, high cholesterol, diabetes and heart disease. It is not clear what causes PCOS, but it is known to be passed down generational lines and can be influenced by lifestyle. I was finally diagnosed with PCOS last year, at 30, and have been on a journey to understand what that means ever since. The thing that leaped out at me early on (and has since been uncovered by the BBC) is just how much information, and misinformation, exists around the condition. My Instagram feed is filled with medically unqualified influencers. Sorting through all that to figure out which nutritionists and health professionals to pay attention to, in the absence of adequate support from the doctors and nurses who gave me that initial assessment and diagnosis, has been a battle. I've been encouraged to adopt unrealistic diets (so-called 'PCOS nutritionists' often suggest cutting out gluten, dairy and carbohydrates, despite a lack of evidence to show this is sustainable or useful for the condition); take unregulated supplements that can have significant side-effects; and sign up to expensive health plans and apps. I've been told to stop doing cardio and focus instead on weights and walking, because of the misguided idea that high-intensity exercise will cause my cortisol levels to rise to the degree that it will worsen my symptoms. In reality, all types of exercise can be beneficial. Medical misogyny has been well documented, and women's healthcare is rarely taken seriously. I first asked my GP about symptoms during the pandemic, when, after a blood test, I was told that my hormone levels were normal and I didn't have the condition. Later, having an ultrasound for an unrelated matter, I was unceremoniously told that I had lots of follicles on my ovaries and probably had PCOS. When I mentioned the earlier blood test, the sonographer told me that this is not a good way to diagnose the condition, especially if you are using hormonal birth control. Confusingly, PCOS does not cause cysts on the ovaries. 'They're not actual true cysts,' says Helena Teede, an Australian endocrinologist and expert in PCOS at Monash University in Melbourne. 'They're follicles or eggs that are just developing along a pathway, but they stop developing normally because they don't like the hormones that they're floating around in.' There has long been chatter about renaming PCOS to something that is more representative of the breadth of symptoms it causes. The current name, Teede says, 'completely misses the fact that this is a hormonal condition; that it has long-term impacts; that it is psychological, dermatological, metabolic, reproductive and, beyond fertility, it goes into many other reproductive features. And it really has an impact on quality of life.' She says it's likely that the process to give it a new name will be completed this year – her organisation has opened a survey for anyone who wants to contribute. Another myth is that women with the condition have a significant 'excess' of testosterone. And PCOS does open up some interesting questions about gender. But, says Teede, the idea that testosterone is an exclusively male hormone is false. Plus, women with PCOS do not typically have elevated levels of testosterone; it's more that our bodies are not very good at dealing with it. We have much less of the hormone than most men. After my diagnosis at the ultrasound, I had a follow-up call with a nurse practitioner, where I was told simply that I should put up with my symptoms but come back when I wanted to get pregnant; because, of course, that is the only thing that young women aspire to. When I pushed, I was offered a drug named metformin, which is used to treat insulin resistance and diabetes. It wasn't explained to me how this drug works and why it would be useful for my specific case. But, I have since learned, insulin resistance – when your body struggles to regulate your blood sugar levels – is one of the hallmark symptoms of PCOS and triggers a lot of the other issues that people with the condition face. Teede, however, points out that 'every woman has a different problem and a different life stage that's most important to them, and it's about their interpretation'. Doctors should think holistically about treatment plans for women with PCOS and listen to their concerns. My own contrasting experience, though, is much more common, says Rachel Morman, the chair of the UK PCOS charity Verity: 'After 20 years of doing this work, I'm like: 'Why is this still happening?'' She had a similar conversation with doctors after she was diagnosed in the early 00s, with the added shock of being told that she wouldn't be able to have children at all. While it is true that about 70% of women with PCOS experience fertility struggles, after intervention that number drops significantly; the vast majority of women with the condition are able to get pregnant. Morman has three children now. It's also important for women to know that a lot of the risks associated with PCOS in pregnancy (such as miscarriage, gestational diabetes and pre-eclampsia) are preventable. Before they start trying for a baby, women with the condition should have a full diabetes test and get their blood pressure checked, as well as aim for a healthy diet and active lifestyle. But when doctors tell us that PCOS is something we should be concerned about only if we want to get pregnant, that is extremely frustrating, considering the wide range of effects it has on our bodies. Morman says that while there is a lot more information available now than when she was diagnosed, some treatment options have become worse: hair removal treatments used to be offered on the NHS for women diagnosed with PCOS, but not any more. As Teede acknowledges: 'One of the reasons why people go to alternative sources of information is because they're not satisfied with what they get from the health practitioners.' Misinformation about PCOS abounds, and much of it is repeated by medical professionals. To help counteract this, Teede helped to develop the extensively researched international evidence-based guidelines for PCOS in 2023, which I now regard as the holy grail of information about the condition. Her team has also created an app called AskPCOS, which can help women to find the right treatment pathways. It doesn't cover everything, but it is thorough, uses up-to-date research and doesn't make bold claims about 'curing' PCOS, as some people do on social media. 'There are a whole lot of individual practitioners, most of whom are not actually practitioners, who are there for financial gain,' says Teede. 'The biggest challenge I have is the misinformation, and then associated with that, the harm that's done by denigrating actual evidence-based strategies. Which, in the end, does a disservice for women with the condition.' She is not wholly against what she terms 'complementary therapies' (ie supplements and diets), as long as women undertake them clear-eyed and unswayed by false claims. But she does not believe people will stop looking to these types of practitioners for support until there are more trustworthy medical repositories, alongside legal liability for people who provide misinformation. Having researched PCOS over the past year (though there's still much to learn), here's what I've tried: in terms of monitoring the metabolic symptoms, I've checked my blood pressure and had screenings for diabetes and high cholesterol. My levels were fine. I've come off my birth control (some types of pill can help with the symptoms of PCOS; this one didn't) and started taking a well-researched supplement called myo-inositol, which may help with insulin resistance. But I've since come off it because it made me dizzy, a known side-effect for some people. I get periods most months, though I did so before I was put on the pill in my teens, so this may not have affected my ovulation. In terms of cosmetic treatments, I have moved away from laser hair removal, which can cause women with PCOS to experience paradoxical hypertrichosis – the regrowth of darker hairs, seemingly stimulated by the laser. Instead, I have begun electrolysis, the only way to permanently remove hairs. I'm on a break from it as the treatment has been slow and moderately painful, causing breakouts that take weeks to heal. Thankfully, the acne on my face has never been severe, but I have got topical treatment for it from an online dermatologist and benzoyl peroxide from my GP. My body acne has taken longer to get under control; I had a private online consultation with a dermatologist, which cost me £100, and have found reasonably priced skincare products that mostly work for me (shout out to Cerave). The reason I am sharing this is not so that others with PCOS can attempt to mirror my journey. Everyone is different. For example, some women are comfortable with having visible facial hair. It is not inherently shameful and I hate that it is considered to be so. Instead, I am sharing because it shows how much time and energy I have had to put into dealing with PCOS. As it stands, all women with the condition need to go on a journey of evidence-based self-education, because it is unlikely that their primary care doctors will be able to adequately direct them, and there are very few accessible specialists. We have to test out treatments and cosmetic procedures – many unregulated – for ourselves, working through trial and error. Perhaps one of the biggest learnings I've taken from this year has been around mental expenditure. While we undoubtedly have to demand better treatment from our doctors, and ask them to seek out research, those of us with chronic conditions have personal choices to make. Even in an ideal system, where I could be supported on and off medication with all the necessary tests, I would still have to make a judgment call about how much time and energy to invest in 'managing' my PCOS. It is lifelong and incurable, and, for me at least, learning to live with it has become just as important as tackling some of the issues that it causes. That is not to say people with PCOS should give up – learn to embrace their facial hair or uncomfortable acne, or the more serious difficulties related to heart health or diabetes – but it does move it in my mind from a space of hopelessness to one of pragmatism. And it has allowed me to give myself a mental break. 'You do need to have at least four periods a year, because otherwise it's a higher risk of getting cancer of the womb, for example,' says Teede. She says that people with PCOS must go for an annual checkup, including blood pressure tests. 'But you don't need to carry that around permanently,' she adds. The other brilliant news is that, in the background, things are changing. A new study shows that awareness of the syndrome has grown massively in the past eight years. In the UK, there is collaborative work happening to make sure that the syndrome becomes a research priority, including an all-party parliamentary group. 'We'll actually have proper pathways for PCOS treatment, so hopefully that should improve standard of care,' says Morman. For me, I had my foray into the land of misinformation and I battled my way out of it. I have sought out community with other women who have the condition, and I'm taking steps to mitigate its potential effect on my fertility in the future. Most of all, I feel incredibly thankful that I have been diagnosed in an era where there are women like Teede and Morman who are fighting for the recognition and evidence-based treatment of PCOS. We are not at a loss. We are at the bright beginning.
Reuters
an hour ago
- Reuters
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
June 22 (Reuters) - Novo Nordisk ( opens new tab on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and other outcome results, including blood sugar levels, were positive. The company had previously announced top-line results for the 68-week studies, which found that CagriSema led to nearly 23% weight loss for overweight or obese adults, while overweight type 2 diabetics lost nearly 16% of their weight. Those results, however, disappointed investors, sending Novo's shares lower. The company last month ousted its CEO Lars Fruergaard Jorgensen. The full Phase 3 results were presented in Chicago at the annual meeting of the American Diabetes Association and published in the New England Journal of Medicine. In the obesity trial, 79.6% of CagriSema patients had mainly transient, mild-to-moderate gastrointestinal effects such as nausea, vomiting and constipation, compared with 39.9% of placebo patients. Serious adverse events occurred in 9.8% of CagriSema patients and 6.1% of placebo patients. In the CagriSema group, 6% of patients dropped out of the trial due to adverse events, compared with 3.7% in the placebo group. "Everything was in line with what we expected," Dr. Melanie Davies, lead investigator of the CagriSema diabetes trial, and co-director of the Leicester Diabetes Centre, told Reuters. The percentage of patients who had a glycated hemoglobin, or blood sugar, level of 6.5% or less was 73.5% in the CagriSema group and 15.9% in the placebo group. Dr. Davies acknowledged questions about why many patients in the trials were not given the highest tested dose. "Those patients on lower doses actually had higher weight loss reduction," she said. "We've not really seen that before because we have not had powerful treatments that have got people close to target." CagriSema is a weekly injection that combines Novo's blockbuster GLP-1 drug Wegovy with another molecule, cagrilintide, that mimics a hunger-suppressing pancreatic hormone called amylin. The CagriSema Phase 3 trial results "compared very favorably also with what we've seen with tirzepatide, which was previously the best-in-class," Dr. Davies said. Eli Lilly's (LLY.N), opens new tab tirzepatide, sold under the brand name Zepbound for weight loss, works by stimulating GLP-1 along with a second gut hormone called GIP. It was shown to help obese and overweight adults lose 22% of their weight over 72 weeks. Dr. Davies said it makes sense to have more options for patients, including "theoretical benefits" with amylin, which has been shown in animal studies to boost energy expenditure. If that effect is seen in humans, it could help mitigate the body's metabolic adaptation to weight loss, she said. Novo Nordisk said it plans to file for regulatory approvals for CagriSema in the first quarter of 2026. "We expect to see approval maybe around the beginning of 2027," Martin Holst Lange, head of development at Novo Nordisk, told Reuters. The company is conducting several other trials of CagriSema, including measuring its impact on cardiovascular outcomes. Lange said trial patients given lower doses of the drug often lost as much weight as those given higher doses, suggesting the need for flexibility including longer time periods between dose escalation. "This also allows them to lose their body weight at a pace that isn't too steep. It also mitigates side effects," he said.
